TAM
STAB

Taurus Asset Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Taurus Asset Management’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-750
Closed -$7K – 103
2014
Q3 		$7K Hold
750
– – ﹤0.01% 100
2014
Q2 		$7K Hold
750
– – ﹤0.01% 101
2014
Q1 		$10K Hold
750
– – ﹤0.01% 105
2013
Q4 		$18K Hold
750
– – ﹤0.01% 107
2013
Q3 		$24K Hold
750
– – 0.01% 103
2013
Q2 		$24K Buy
+750
New +$25.8K 0.01% 103

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Taurus Asset Management's STAB Position: Q4 2014 in Review

Taurus Asset Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2014, closing a stake of 750 shares — an estimated $7K sold.

Taurus Asset Management first reported a position in STAB in Q2 2013 and held it in 6 quarters. The position peaked at $24K in Q3 2013. 24 funds tracked by Wall St. Rank hold STAB as of Q4 2014.

  • Taurus Asset Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Taurus Asset Management sold 750 Statera Biopharma, Inc. Common Stock shares in Q4 2014, an estimated $7K.
  • Taurus Asset Management first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • Taurus Asset Management's Statera Biopharma, Inc. Common Stock position peaked at $24K in Q3 2013.
  • 24 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2014.

Based on Taurus Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.